ADVFN US – Market Content Editor
-
U.S. Jobless Claims Edge Higher but Remain Below Expectations
New filings for U.S. unemployment benefits rose slightly last week, according to data released Thursday by the Labor Department, pointing to continued resilience in the labor market. Initial jobless claims totaled 212,000 for the week ended February 21, increasing by 4,000 from the prior week’s revised figure of 208,000. The reading came in below economists’…
-
Mixed earnings signals point to uneven start for Wall Street: Dow Jones, S&P, Nasdaq, Futures
U.S. stock index futures indicated a largely flat opening on Thursday, suggesting markets may struggle to find clear direction after two consecutive sessions of strong gains. Investor sentiment appeared divided following earnings updates from Dow components Nvidia (NASDAQ:NVDA) and Salesforce (NYSE:CRM), setting the stage for potentially volatile and uneven trading. Nvidia shares climbed about 1.0%…
-
Krispy Kreme jumps nearly 15% after earnings beat signals turnaround momentum
Krispy Kreme, Inc. (NASDAQ:DNUT) shares climbed sharply in premarket trading Thursday after the doughnut maker delivered stronger-than-expected fourth-quarter results and pointed to continued progress in its business turnaround strategy. The stock rose 14.72% before the opening bell as investors reacted positively to improved profitability and balance sheet strengthening despite a modest decline in revenue. Earnings…
-
Hormel warns turkey business divestment will trim annual sales but have limited earnings impact
Hormel Foods Corp. (NYSE:HRL) said the planned sale of its whole-bird turkey business is expected to reduce annual net sales by roughly $50 million, though the company anticipates only a minimal effect on overall earnings. The food producer recently reached an agreement to sell the unit to Minnesota-based Life-Science Innovations, but financial terms of the…
-
Eli Lilly’s oral drug orforglipron shows stronger results than oral semaglutide in diabetes study
Eli Lilly and Company (NYSE:LLY) said its experimental oral diabetes treatment orforglipron delivered superior blood sugar reduction and weight-loss outcomes compared with oral semaglutide in a head-to-head clinical study published in The Lancet. The findings come from the 52-week ACHIEVE-3 trial, which enrolled 1,698 patients with type 2 diabetes and compared multiple dosing regimens of…
-
Donaldson shares slide after earnings miss and weaker profit outlook
Donaldson Company (NYSE:DCI) shares fell more than 4% in premarket trading Thursday after the filtration products manufacturer reported quarterly results that missed analyst expectations and lowered parts of its fiscal 2026 outlook. The stock declined 4.39% ahead of the U.S. market open following the earnings release. The company posted adjusted earnings per share of $0.83…
-
Privia Health tops forecasts on strong fourth-quarter earnings and revenue growth
Privia Health Group, Inc. (NASDAQ:PRVA) reported fourth-quarter results that surpassed Wall Street expectations on Thursday, driven by continued expansion in its physician network and strong operating performance, although the company’s shares edged slightly lower in premarket trading. The stock slipped 0.18% ahead of the market open following the announcement. The healthcare services company posted adjusted…
-
Titan International tops fourth-quarter revenue forecasts as margins improve
Titan International, Inc. (NYSE:TWI) reported fourth-quarter revenue ahead of market expectations on Thursday, supported by stronger performance in its earthmoving and construction business, although the company’s shares were little changed in after-hours trading. The off-highway equipment manufacturer generated revenue of $410 million for the quarter, surpassing analyst estimates of $401.87 million and representing a 7%…
-
Celsius shares jump after strong fourth-quarter revenue beat driven by acquisitions
Celsius Holdings Inc. (NASDAQ:CELH) saw its shares surge in premarket trading after reporting fourth-quarter results that topped Wall Street expectations, supported by rapid revenue growth following recent acquisitions. The company posted adjusted earnings per share of $0.26, exceeding analyst forecasts of $0.19 by $0.07. Quarterly revenue climbed 117% year over year to $721.6 million, ahead…
-
Qnity Electronics gains after strong earnings beat highlights post-spin-off momentum
Shares of Qnity Electronics Inc. (NYSE:Q) rose more than 2% in premarket trading Thursday after the semiconductor technology solutions company reported fourth-quarter results that comfortably exceeded analyst expectations, underscoring solid performance following its recent separation from DuPont. The stock advanced 2.57% ahead of the market open after the company posted adjusted earnings per share of…